Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06006637 · ClinicalTrials.gov registry record · NA

Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

A NA study of Autism Spectrum Disorder, sponsored by State University of New York - Upstate Medical University.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
2
Study locations

NCT06006637 is a NA study of Autism Spectrum Disorder that is actively recruiting participants, run by State University of New York - Upstate Medical University. The registered enrollment target is 80 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (41% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06006637, a NA study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by State University of New York - Upstate Medical University.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
2
Study locations

Study Summary

This study will consist of a randomized, double-blind, sham-controlled clinical trial at SUNY Upstate Medical University and Mt. Sinai Medical Center with 80 autistic children evaluating the effects of transcranial photobiomodulation (tPBM) on multiple clinically validated scales.

Conditions Studied

Autism Spectrum Disorder

Interventions

  • DEVICE Cognilum TM: Light Treatment Condition

Study Locations (2)

New York

  • Mt. Sinai Medical Center - New York
  • Golisano Center for Special Needs - Syracuse

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-10-17
Est. Completion 2026-08-15
Phase NA

Sponsor

State University of New York - Upstate Medical University

113 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06006637

The ClinicalTrials.gov registry entry for NCT06006637 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (41% lower). The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Cognilum TM: Light Treatment Condition is the first listed.

NCT06006637 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06006637 about?

NCT06006637 is a clinical study titled "Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder". This study will consist of a randomized, double-blind, sham-controlled clinical trial at SUNY Upstate Medical University and Mt. Sinai Medical Center with 80 autistic children evaluating the effects of transcranial photobiomodulation (tPBM) on multiple clinically validated scales.

What is the current status of trial NCT06006637?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-10-17. Estimated completion is 2026-08-15.

What conditions does trial NCT06006637 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT06006637?

The interventions under investigation include: Cognilum TM: Light Treatment Condition (DEVICE).

Who is sponsoring clinical trial NCT06006637?

This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06006637 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autism Spectrum Disorder

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.